| Drug Name |
Ferric citrate |
| Drug ID |
BADD_D02402 |
| Description |
Tetraferric tricitrate decahydrate is an iron containing phosphate binder used to treat hyperphosphatemia and iron deficiency anemia in adults with chronic kidney disease.[A25965]
Tetraferric tricitrate decahydrate was granted FDA approval on 5 September 2014.[L9926] |
| Indications and Usage |
Not Available |
| Marketing Status |
Not Available |
| ATC Code |
V03AE08 |
| DrugBank ID |
DB14520
|
| KEGG ID |
D09993
|
| MeSH ID |
C025314
|
| PubChem ID |
61300
|
| TTD Drug ID |
D04CJL
|
| NDC Product Code |
57297-144; 53296-0117; 17511-124; 58159-035; 0792-0046; 65675-1114; 66499-0069; 59922-631 |
| Synonyms |
ferric citrate | iron(III) citrate | ferric-citric acid | ferric citrate anhydrous | ferric citrate hydrate | JTT-751 | zerenex | ferric citrate trihydrate | ferric citrate, 59Fe-labeled cpd | ferric citrate, iron salt, 59Fe-labeled cpd | ferric citrate dihydrate | ferric citrate iron(+3) salt |
